Biofrontera Inc.
Clinical trials sponsored by Biofrontera Inc., explained in plain language.
-
New light therapy shows promise for treating skin cancer without surgery
Disease control OngoingThis study tests a gel called Ameluz® that is activated by a special red light to treat a common type of skin cancer called superficial basal cell carcinoma. About 187 adults with at least one skin cancer lesion will receive either the active gel or a placebo, followed by light t…
Phase: PHASE3 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated May 26, 2026 10:47 UTC
-
New gel plus light therapy could clear precancerous skin spots
Disease control OngoingThis study tests a gel (Ameluz®) combined with a special red light to treat actinic keratosis—rough, scaly patches caused by sun damage that can turn into skin cancer. About 172 adults with 4 to 15 patches on their arms, legs, neck, or trunk will receive either the active gel or …
Phase: PHASE3 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated May 26, 2026 10:43 UTC
-
New light therapy could zap stubborn acne
Disease control OngoingThis study tests a light-based treatment called photodynamic therapy (PDT) using a special gel (Ameluz®) and a lamp (BF-RhodoLED®) for adults with moderate to severe acne. About 126 participants will receive either the active treatment or a placebo gel to see if it safely reduces…
Phase: PHASE2 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC